ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

10x Genomics, Inc. - Common Stock (NQ:TXG)

20.36 +0.55 (+2.80%)

Streaming Delayed Price Updated: 2:53 PM EST, Jan 13, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,660,384
Open	19.94
Bid (Size)	20.35 (200)
Ask (Size)	20.36 (200)
Prev. Close	19.80
Today's Range	19.50 - 20.73
52wk Range	6.780 - 21.18
Shares Outstanding	109,588,527
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

1 Cash-Heavy Stock to Consider Right Now and 2 We Question

January 12, 2026

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

Why 10x Genomics (TXG) Shares Are Falling Today

January 12, 2026

Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 4.7% in the afternoon session after the company announced weak preliminary results for its fourth quarter and full year 2025, which pointed to a...

Via StockStory

Performance

YTD	+22.5%	+22.5%
1 Month	+29.2%	+29.2%
3 Month	+75.5%	+75.5%
6 Month	+63.2%	+63.2%
1 Year	+29.6%	+29.6%

More News

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

January 07, 2026

From CareDx, Inc.

Via Business Wire

10x Genomics (TXG) Stock Is Up, What You Need To Know

January 02, 2026

Via StockStory

2 Russell 2000 Stocks Worth Investigating and 1 We Avoid

January 01, 2026

Via StockStory

10x Genomics (TXG) Stock Trades Up, Here Is Why

December 22, 2025

Via StockStory

1 Stock Under $50 Worth Your Attention and 2 We Turn Down

December 21, 2025

Via StockStory

10x Genomics (TXG) Q2 2025 Earnings Transcript ↗

December 11, 2025

Via The Motley Fool

10x Genomics (TXG) Q4 2024 Earnings Transcript ↗

December 11, 2025

Via The Motley Fool

Why 10x Genomics (TXG) Stock Is Nosediving

December 11, 2025

Via StockStory

Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders

December 07, 2025

Via StockStory

3 Unprofitable Stocks with Questionable Fundamentals

December 03, 2025

Via StockStory

10x Genomics (TXG) Q3 2025 Earnings Transcript ↗

November 27, 2025

Via The Motley Fool

BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know

November 24, 2025

Via StockStory

Bruker, 10x Genomics, PacBio, ICU Medical, and Dentsply Sirona Shares Skyrocket, What You Need To Know

November 21, 2025

Via StockStory

3 Reasons to Avoid TXG and 1 Stock to Buy Instead

November 18, 2025

Via StockStory

1 Momentum Stock with Promising Prospects and 2 We Avoid

November 13, 2025

Via StockStory

5 Insightful Analyst Questions From 10x Genomics’s Q3 Earnings Call

November 13, 2025

Via StockStory

1 Small-Cap Stock for Long-Term Investors and 2 We Avoid

November 11, 2025

Via StockStory

Why 10x Genomics (TXG) Stock Is Trading Up Today

November 11, 2025

Via StockStory

Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3

November 10, 2025

Via StockStory

3 Russell 2000 Stocks We Approach with Caution

November 09, 2025

Via StockStory

Why 10x Genomics (TXG) Stock Is Trading Up Today

November 07, 2025

Via StockStory

TXG Q3 Deep Dive: Spatial Biology and Consumables Drive Outperformance Amid Macro Uncertainty

November 07, 2025

Via StockStory

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 07, 2025

Via Benzinga

Frequently Asked Questions

Is 10x Genomics, Inc. - Common Stock publicly traded?

Yes, 10x Genomics, Inc. - Common Stock is publicly traded.

What exchange does 10x Genomics, Inc. - Common Stock trade on?

10x Genomics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for 10x Genomics, Inc. - Common Stock?

The ticker symbol for 10x Genomics, Inc. - Common Stock is TXG on the Nasdaq Stock Market

What is the current price of 10x Genomics, Inc. - Common Stock?

The current price of 10x Genomics, Inc. - Common Stock is 20.36

When was 10x Genomics, Inc. - Common Stock last traded?

The last trade of 10x Genomics, Inc. - Common Stock was at 01/13/26 02:53 PM ET

What is the market capitalization of 10x Genomics, Inc. - Common Stock?

The market capitalization of 10x Genomics, Inc. - Common Stock is 2.23B

How many shares of 10x Genomics, Inc. - Common Stock are outstanding?

10x Genomics, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.